Juan Jose Marugan,Jingbo Xiao,Marc Ferrer-Alegre,Catherine Chen,Noel Southall,Wei Zheng,Alexander Agoulnik,Irina Agoulnik
申请号：
US15247438
公开号：
US10125112B2
申请日:
2016.08.25
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Disclosed are modulators of the human relaxin receptor 1, for example, of formula (I), wherein A, R1, and R2 are as defined herein, that are useful in treating mammalian relaxin receptor 1 mediated facets of human health, e.g., cardiovascular disease. Also disclosed is a composition comprising a pharmaceutically suitable carrier and at least one compound of the disclosure, and a method for therapeutic intervention in a facet of mammalian health that is mediated by a human relaxin receptor 1.
